Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status

被引：34

作者：

McCredie, MRE

Dite, GS

Southey, MC

Venter, DJ

Giles, GG

Hopper, JL

机构：

[1] Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic 3053, Australia

[2] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand

[3] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia

[4] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia

[5] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia

[6] Canc Council New S Wales, Canc Epidemiol Res Unit, Sydney, NSW, Australia

来源：

BRITISH JOURNAL OF CANCER | 2003年 / 89卷 / 09期

关键词：

breast cancer in young women; epidemiology; oestrogen and progesterone receptor status;

D O I：

10.1038/sj.bjc.6601293

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We used data from 765 cases and 564 controls in the population-based Australian Breast Cancer Family Study to investigate whether, in women under the age of 40, the profile of risk factors differed between breast cancer subtypes defined by joint oestrogen and progesterone receptor status. As hypothesised, no significant differences were found.

引用

页码：1661 / 1663

页数：3

共 50 条

[31] Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
R Suzuki
T Rylander-Rudqvist
S Saji
L Bergkvist
H Adlercreutz
A Wolk
British Journal of Cancer, 2008, 98 : 636 - 640
[32] Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Aebi, S
Gelber, S
Castiglione-Gertsch, M
Gelber, RD
Collins, J
Thürlimann, B
Rudenstam, CM
Lindtner, J
Crivellari, D
Cortes-Funes, H
Simoncini, E
Werner, ID
Coates, AS
Goldhirsch, A
LANCET, 2000, 355 (9218): : 1869 - 1874
[33] Dietary lignans and postmenopausal breast cancer risk by oestrogen receptor status: a prospective cohort study of Swedish women
Suzuki, R.
Rylander-Rudqvist, T.
Saji, S.
Bergkvist, L.
Adlercreutz, H.
Wolk, A.
BRITISH JOURNAL OF CANCER, 2008, 98 (03) : 636 - 640
[34] Oestrogen receptor status and survival in women with BRCA2-associated breast cancer
Metcalfe, Kelly
Lynch, Henry T.
Foulkes, William D.
Tung, Nadine
Olopade, Olufunmilayo, I
Eisen, Andrea
Lerner-Ellis, Jordan
Snyder, Carrie
Kim, Shana J.
Sun, Ping
Narod, Steven A.
BRITISH JOURNAL OF CANCER, 2019, 120 (04) : 398 - 403
[35] Oestrogen receptor status and survival in women with BRCA2-associated breast cancer
Kelly Metcalfe
Henry T. Lynch
William D. Foulkes
Nadine Tung
Olufunmilayo I. Olopade
Andrea Eisen
Jordan Lerner-Ellis
Carrie Snyder
Shana J. Kim
Ping Sun
Steven A. Narod
British Journal of Cancer, 2019, 120 : 398 - 403
[36] SOCIOECONOMIC STATUS AND BREAST CANCER MORTALITY IN SCOTLAND BY OESTROGEN RECEPTOR STATUS
Mesa-Eguiagaray, I.
Wild, S.
Figueroa, J.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2019, 73 : A15 - A15
[37] The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer
Xu, Wei
Huang, Minghua
Guo, Jia
Zhang, Huiting
Wang, Depeng
Liu, Tiantian
Liu, Hafting
Chen, Shiming
Gao, Peng
Mu, Kun
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (08): : 1388 - 1402
[38] The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
Davey, M. G.
Ryan, E. J.
Folan, P. J.
O'Halloran, N.
Boland, M. R.
Barry, M. K.
Sweeney, K. J.
Malone, C. M.
McLaughlin, R. J.
Kerin, M. J.
Lowery, A. J.
BJS OPEN, 2021, 5 (03):
[39] Oestrogen Receptor Negative Progesterone Receptor Positive Phenotype in Breast Cancer is a Technical Artefact.
Rakha, E. A.
Roberts, J.
Ahmed, Z.
Ellis, I. O.
Lee, A. H.
Green, A.
JOURNAL OF PATHOLOGY, 2012, 228 : S22 - S22
[40] Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status
Honma, N
Sakamoto, G
Akiyama, F
Esaki, Y
Sawabe, M
Arai, T
Hosoi, T
Harada, N
Younes, M
Takubo, K
HISTOPATHOLOGY, 2003, 42 (02) : 120 - 127

← 1 2 3 4 5 →